Trial · NCT03835819
Adverse events120
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 120
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | IMGN853 + Pembrolizumab | 10 | 18 | |
| other | Sinus tachycardia | Cardiac disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Hearing impaired | Ear and labyrinth disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Adrenal insufficiency | Endocrine disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Hyperthyroidism | Endocrine disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Hypothyroidism | Endocrine disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Blurred vision | Eye disorders | IMGN853 + Pembrolizumab | 8 | 18 | |
| other | Cataract | Eye disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Dry eye | Eye disorders | IMGN853 + Pembrolizumab | 2 | 18 | |
| other | Eye disorders - Other, specify | Eye disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Photophobia | Eye disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Abdominal distention | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 2 | 18 | |
| other | Abdominal pain | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 7 | 18 | |
| other | Ascites | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Belching | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 1 | 18 | |
| other | Bloating | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 2 | 18 | |
| other | Constipation | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 4 | 18 | |
| other | Diarrhea | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 9 | 18 | |
| other | Dry mouth | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 2 | 18 | |
| other | Dyspepsia | Gastrointestinal disorders | IMGN853 + Pembrolizumab | 2 | 18 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03835819/events